Haploidentical cord blood transplant contaminated with maternal T cells in a patient with advanced leukaemia

Bone Marrow Transplantation

Volumn 17, Issue 5, 1996, Pages 891-895

  Abecasis, M M ^a   Machado, A M ^a   Boavida, G ^b   Silva, M G ^a   Lucio P ^a   Ambrosio A ^a   Jorge, M L ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Cord blood transplantation; Haploidentical; Maternal T cell contamination

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; HLA ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; BLAST CELL CRISIS; CASE REPORT; CELL TRANSPLANTATION; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CONTAMINATION; DNA DETERMINATION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIBLING; T LYMPHOCYTE; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

CHIMERA; FAMILY; FEMALE; FETAL BLOOD; GRAFT SURVIVAL; HAPLOTYPES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LIVING DONORS; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; T-LYMPHOCYTES; TIME FACTORS;

EID: 0030006661     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Spencer A, O'Brien SG, Goldman JM. Options for therapy in chronic myeloid leukaemia. Br J Haematol 1995; 91: 2-7.
2. Allan NC, Richards SM, Shepherd PLA, on behalf of the Medical Research Council's Working Parties for Therapeutic Trials in Acute Leukaemia. Results of the Medical Research Council randomised multi-centre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. Lancet 1995; 345: 1392-1397.
3. Gratwohl A. Hermans J. Niederwieser D et al for the Chronic Myeloid Leukaemia Working Party of the European Group for Bone Marrow Transplantation. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Bone Marrow Transplant 1993; 12: 509-516.
4. Wagner JE, Kernan NA. Steinbuch M et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214-219.
5. Han P, Hodge G, Story C, Xu X. Phenotypic analysis of functional T-lymphocyte subsets and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br J Haematol 1995: 89: 733-740.
6. Risdon G, Gaddy J, Stehman FB, Broxmeyer HE. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 1994; 154: 14-24.
7. Socié G. Gluckman E, Carosella E et al. Search for maternal cells in human umbilical cord by polymerase chain reaction amplification of two minisatellite sequences. Blood 1994; 83: 340-344.
8. Hall J, Lingfelter P, Adams SL et al. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 1995; 86: 2829-2832.
9. Beatty PG, Cliff RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings. New Engl J Med 1985; 313: 765-771.
10. Turner CW, Luzins J, Hutcheson C. A modified harvest technique for cord blood hematopoietic stem cells. Bone Marrow Transplant 1992; 10: 89-91.
11. Gluckman E. Broxmeyer HE. Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical cord blood from an HLA-identical sibling. New Engl J Med 1989; 321: 1174-1178.
12. Wagner JE, Broxmeyer HE, Byrd RL et al. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood 1992; 79: 1874-1881.
13. Vilmer E, Sterkers G. Rahimy C et al. HLA-mismatched cord blood transplantation in a patient with advanced leukemia. Transplantation 1992; 53: 1155-1157.
14. Bogdanic V, Nemet D, Kastelan A et al. Umbilical cord blood transplantation in a patient with Philadelphia chromosome positive chronic myeloid leukemia. Transplantation 1993; 56: 477-479.
15. Issaragrisil S, Visuthisakchai S, Suvatte V et al. Transplantation of cord blood stem cells into a patient with severe thalassemia. New Engl J Med 1995; 332: 367-369.
16. Miniero R, Busce A, Roncarolo MG et al. HLA-haploidentical umbilical cord blood stem cell transplantation in a child with advanced leukemia: clinical outcome and analysis of hematopoietic recovery. Bone Marrow Transplant 1995; 16: 229-240.
17. van Rood JJ, Claas FHJ. The influence of allogeneic cells on the human T and B cell repertoire. Science 1990; 248: 1388-1393.
18. Claas FHJ, Gijbels van der Velden, van Rood JJ. Induction of B cell unresponsiveness to non-inherited maternal HLA antigens during fetal life. Science 1989; 241: 1815-1817.
19. Hunziner RD, Gambel P, Wegmann TG. Placenta as a selective barrier to cellular traffic. J Immunol 1984; 133: 667-676.
20. Papadogiannakis N, Johnson JA, Olding LB. Suppressor cell activity in human cord blood. In: Chaouat G (ed). Immunology of the Fetus. CRC Press: Boca Raton, FL, 1990, pp 215-227.
21. Harris DT, Schumacher MJ, Locascio J et al. Immunoreactivity of umbilical cord blood and post-partum maternal peripheral blood with regard to HLA haploidentical transplantation. Bone Marrow Transplant 1994; 14: 63-68.
22. Hansen JA. HLA and marrow transplants from unrelated donors. Exp Hematol 1994; 22: 677a (abstr.).